...

 
Cannvas.Me
Sign Up For Free
  • Post Time Posted October 01, 2018
According to a recently released internal government letter sent from the Food and Drug Administration (FDA),  to the U.S. Drug Enforcement Administration (DEA), cannabidiol, or CBD, does not meet the criteria for federal control. 

The letter came through the process of the FDA’s due diligence of the recently approved CBD based drug Epidiolex.

The FDA wrote to the DEA in May that studies demonstrated that “CBD and its salts… do not have a significant potential for abuse and could be removed from the [Controlled Substances Act].” 

The DEA responded by stating that if the U.S. were to deschedule CBD it would violate “its obligations under the 1961 Single Convention on Narcotic Drugs,” and as a result refrained from doing so.
 
Source: https://www.marijuanamoment.net/fda-says-marijuana-ingredient-cbd-doesnt-meet-criteria-for-federal-control/


This article is now marked as read.

Was this article helpful?

Review this article to help us continue creating and sharing relevant content.

Please note it may take up to two business days for reviews to be validated and published.

Reviews

Review this article to help us continue creating and sharing relevant content.

Write Review

Would you like to
make this review public?

Please disable your ad blocker to avoid issues using social plugins on Cannvas.Me. Thanks.
Close